Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/30340
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SCHREZENMEIER, H. | |
dc.contributor.author | LEE, J. W. | |
dc.contributor.author | ROTTINGHAUS, S. T. | |
dc.contributor.author | LEE, Lee L. W. | |
dc.contributor.author | PESSOA, V. | |
dc.contributor.author | GUALANDRO, S. | |
dc.contributor.author | FUEREDER, W. | |
dc.contributor.author | PTUSHKIN, V. | |
dc.contributor.author | FONTBRUNE, Sicre F. de | |
dc.contributor.author | VOLLES, L. | |
dc.contributor.author | SHAFNER, L. | |
dc.contributor.author | DAMOKOSH, A. I. | |
dc.contributor.author | AGUZZI, R. | |
dc.contributor.author | PRADHAN, R. | |
dc.contributor.author | ORTIZ, S. | |
dc.contributor.author | HILL, A. | |
dc.date.accessioned | 2019-01-29T17:08:05Z | - |
dc.date.available | 2019-01-29T17:08:05Z | - |
dc.date.issued | 2018 | |
dc.identifier.citation | ONCOLOGY RESEARCH AND TREATMENT, v.41, suppl.4, p.332-+, 2018 | |
dc.identifier.issn | 2296-5270 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/30340 | - |
dc.language.iso | eng | |
dc.publisher | KARGER | eng |
dc.relation.ispartof | Oncology Research and Treatment | |
dc.rights | restrictedAccess | eng |
dc.title | Results from a phase 3, multicenter, noninferiority study of ravulizumab (ALXN1210) versus eculizumab (ECU) in adult patients (PTS) with paroxysmal nocturnal hemoglobinuria (PNH) naive to complement inhibitors (CI) | eng |
dc.type | conferenceObject | eng |
dc.rights.holder | Copyright KARGER | eng |
dc.subject.wos | Oncology | eng |
dc.type.category | meeting abstract | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | SCHREZENMEIER, H.:Univ Ulm, Inst Clin Transfus Med & Immunogenet, German Red Cross Transfus Serv Baden Wurttemberg, Inst Transfus Med L1, Ulm, Germany; Univ Hosp Ulm, Ulm, Germany | |
hcfmusp.author.external | LEE, J. W.:Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Seoul, South Korea | |
hcfmusp.author.external | ROTTINGHAUS, S. T.:Alexion Pharmaceut Inc, New Haven, CT USA | |
hcfmusp.author.external | LEE, Lee L. W.:Queen Elizabeth Hosp, Hematol Unit, Kota Kinabalu, Malaysia | |
hcfmusp.author.external | PESSOA, V.:Hemorio, Hematol, Rio De Janeiro, Brazil | |
hcfmusp.author.external | FUEREDER, W.:Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria | |
hcfmusp.author.external | PTUSHKIN, V.:SP Botkin Hosp, Outpatient Dept Hematol Oncol & Chemotherapy, Moscow, Russia | |
hcfmusp.author.external | FONTBRUNE, Sicre F. de:Hop St Louis, Paris, France | |
hcfmusp.author.external | VOLLES, L.:Alexion Pharmaceut Inc, New Haven, CT USA | |
hcfmusp.author.external | SHAFNER, L.:Alexion Pharmaceut Inc, New Haven, CT USA | |
hcfmusp.author.external | DAMOKOSH, A. I.:Alexion Pharmaceut Inc, New Haven, CT USA | |
hcfmusp.author.external | AGUZZI, R.:Alexion Pharmaceut Inc, Lexington, MA USA | |
hcfmusp.author.external | PRADHAN, R.:Alexion Pharmaceut Inc, New Haven, CT USA | |
hcfmusp.author.external | ORTIZ, S.:Alexion Pharmaceut Inc, New Haven, CT USA | |
hcfmusp.author.external | HILL, A.:Leeds Teaching Hosp, Dept Haematol, Leeds, W Yorkshire, England | |
hcfmusp.description.beginpage | 332 | |
hcfmusp.description.endpage | + | |
hcfmusp.description.issue | suppl 4 | |
hcfmusp.description.volume | 41 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000446816500815 | |
hcfmusp.publisher.city | BASEL | eng |
hcfmusp.publisher.country | SWITZERLAND | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 2296-5262 | |
Appears in Collections: | Comunicações em Eventos - FM/MCM Comunicações em Eventos - HC/ICHC |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.